Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthcare Times Utah.
Press releases published on September 18, 2025
OrganOx metra® Receives FDA Approval for Operation During Air Transport, Expanding Access to Life-Saving Liver Perfusion Technology
OrganOx Ltd., the organ technology company tackling the world's toughest transplant challenges, announced that its metra® normothermic machine perfusion (NMP) device has received approval from the U.S. Food and Drug Administration (FDA) for operation …
What to know about Medicare changes before you shop for a 2026 plan
Minneapolis, MN, Sept. 18, 2025 (GLOBE NEWSWIRE) -- Millions of Americans will soon have the chance to make critical decisions about their health coverage during the upcoming annual Medicare open enrollment period. Health policy analysts at …
Dark Horse Consulting Group Acquires Converge Consulting
WALNUT CREEK, Calif. and CAMBRIDGE, Mass., Sept. 18, 2025 (GLOBE NEWSWIRE) -- Dark Horse Consulting Group (“DHCG” or “the Group”), a leader in strategic and operational consulting in advanced therapies—specifically the fields of cell and gene therapy (“CGT …
eHealth Exchange 2025 Annual Meeting To Spotlight Innovation, AI, and Future of Interoperability
VIENNA, Va., Sept. 18, 2025 (GLOBE NEWSWIRE) -- In a time when healthcare is being reimagined with advances in artificial intelligence (AI), data exchange, and policy, the eHealth Exchange™ annual meeting will convene leaders, innovators, and trailblazers …
Penn Highlands Healthcare Clinicians Pioneer Opioid-Free ACL Surgery Protocol for Young Athletes
DuBois, Pennsylvania, Sept. 18, 2025 (GLOBE NEWSWIRE) -- In a bold move to combat the opioid crisis and advance surgical recovery, the Orthopedics and Sports Medicine team at Penn Highlands Healthcare has developed a pioneering approach to ACL surgery that …
After Transforming Neuro Care, Sevaro Secures $39M to Expand AI-Powered Specialty Care Platform
NEW YORK, Sept. 18, 2025 (GLOBE NEWSWIRE) -- Sevaro Health, the company transforming neurological care in the United States, today announced the close of a $39 million oversubscribed Series B funding round. The round was led by Valtruis, an investment …
Senti Bio to Present at the MedInvest Biotech & Pharma Conference
SOUTH SAN FRANCISCO, Calif., Sept. 18, 2025 (GLOBE NEWSWIRE) -- Senti Biosciences, Inc. (Nasdaq: SNTI) (“Senti Bio”), a clinical-stage biotechnology company developing next-generation cell and gene therapies using its proprietary Gene Circuit platform, …
Replimune Provides Update Following Type A Meeting with FDA
WOBURN, Mass., Sept. 18, 2025 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (NASDAQ: REPL), a clinical stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today announced that the company completed a Type A meeting with …
BioCardia Announces Pricing of Up To $12 Million Public Offering
SUNNYVALE, Calif., Sept. 18, 2025 (GLOBE NEWSWIRE) -- BioCardia®, Inc. [NASDAQ:BCDA] (“BioCardia” or the “Company”), a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today announced the …
Safety Shot Provides Further Details on Strategic Board Refresh and Corporate Vision
Company to Seek Shareholder Approval for New Director Appointments SCOTTSDALE, AZ, Sept. 18, 2025 (GLOBE NEWSWIRE) -- Following its announcement yesterday regarding a strategic refresh of its Board of Directors, Safety Shot, Inc. (Nasdaq: SHOT) is …
Scientific Industries to Participate in the Lytham Partners Fall 2025 Investor Conference on September 30, 2025
BOHEMIA, N.Y., Sept. 18, 2025 (GLOBE NEWSWIRE) -- Scientific Industries, Inc. (OTCQB: SCND), a developer of digitally simplified bioprocessing products and vision-based pill counters, today announced that it will participate in a webcast presentation and …
Confluent Health Strengthens Leadership to Advance Innovation and Culture in MSK Care
LOUISVILLE, Ky., Sept. 18, 2025 (GLOBE NEWSWIRE) -- Confluent Health, a national leader in musculoskeletal (MSK) care, today announced it has named Scott Farnsworth, MIHS, LPN, PMP, as Chief Information Officer (CIO) and John Lacy as Chief People Officer ( …
SeoProfy Introduces AI SEO Audit to Track LLM Visibility
MIAMI, Sept. 18, 2025 (GLOBE NEWSWIRE) -- SeoProfy has launched a new service designed to help businesses understand and improve their visibility in AI-powered search engines. The AI SEO Audit evaluates how often a brand appears in AI-generated answers …
Commure Awarded as a TIME World’s Top HealthTech Company in 2025
MOUNTAIN VIEW, Calif., Sept. 18, 2025 (GLOBE NEWSWIRE) -- Commure, a leading healthcare technology company, today announced its recognition on TIME’s World’s Top HealthTech Companies for 2025. Commure was featured in two categories, receiving the highest …
TOMI Environmental Solutions, Inc. Announces FDA Broadens Permitted Use of Hydrogen Peroxide; Ruling Significantly Expands Potential Application of SteraMist iHP in Food Industry
FREDERICK, Md., Sept. 18, 2025 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc.® (“TOMI”) (NASDAQ: TOMZ), a global company specializing in disinfection and decontamination solutions, today announced that the U.S. Food and Drug Administration (FDA) …
Study Shows 35% Cost Savings for Medicare Plans While Maintaining High-Quality Outcomes for Patients Living With Serious Illness
NEW YORK CITY, Sept. 18, 2025 (GLOBE NEWSWIRE) -- Empassion Health, Inc., the nation’s largest managed care provider of high-quality care for adults living with serious illness so that they can have more good days, today announced results from its Savings …
Noom Welcomes Rebel Wilson as Chief Wellness Ambassador to Champion Microhabits and Microdose GLP-1s
NEW YORK, Sept. 18, 2025 (GLOBE NEWSWIRE) -- Noom, the leading platform for preventive health, today announced a free tier of its acclaimed wellness app and introduced Rebel Wilson as its Chief Wellness Ambassador. With its new free tier featuring daily …
PDS Biotech Sets Significant Benchmark in Head and Neck Cancer by Achieving Extended Survival in Low PD-L1 Expression (CPS 1–19) Cohort in VERSATILE-002 Trial, Potentially Eliminating Need for Chemotherapy in the Population
First combination therapy to report 29.5 months of Median Overall Survival (mOS); Standard of care Keytruda® (pembrolizumab) alone (10.8 months) and Keytruda® + chemotherapy (12.3 months) in patients with CPS 1-19* Encouraging efficacy signal observed in …
Jyong Biotech Chairwoman and CEO Set to Attend as Speaker at 2025 Global Business Forum in Taipei
New Taipei City, Taiwan, Sept. 18, 2025 (GLOBE NEWSWIRE) -- Jyong Biotech Ltd. (Nasdaq: MENS) (the “Company”, “Jyong Biotech”), a science-driven biotechnology company based in Taiwan committed to developing and commercializing innovative and differentiated …